Biocon Limited announced that the Board of Directors at its meeting held on July 27, 2022, inter alia, has considered the following: Ms. Mary Harney and Mr. Daniel M Bradbury, have completed their tenure with the Company as Independent Directors and consequently ceased to be Directors of the Company with effect from the conclusion of the Board meeting held i.e. July 27, 2022. The Board of Directors and the Management of the Company express deep appreciation and gratitude to both the Directors for their extensive contribution and stewardship.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
314 INR | +1.98% | +2.71% | +25.80% |
07:14am | US FDA Approves Samsung Bioepis' Eye Disease Drug Opuviz | MT |
May. 17 | Jefferies Adjusts Biocon’s Price Target to INR230 From INR250, Keeps at Underperform | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.80% | 4.42B | |
+9.99% | 115B | |
+12.01% | 106B | |
-3.07% | 24.69B | |
-0.67% | 21.97B | |
-4.64% | 19.27B | |
-6.90% | 17.56B | |
-39.36% | 17.32B | |
+5.82% | 14.03B | |
+33.05% | 12.13B |
- Stock Market
- Equities
- BIOCON Stock
- News Biocon Limited
- Biocon Limited Announces Directors Resignation